Precision prescription: Pharmacogenomics in 2025

The completion of the Human Genome Project proposed a genetic revolution in medicine. Pharmacogenomics - one’s genome holding the key for personalised treatments - being one of the most immediate achievements. Yet, more than two decades later, few applications made it to the clinic. This is now about to change with the NHS embarking on a decade of genomic medicine. This workshop brings together leaders in the field, such as Prof William Newman and Dr Ellen McDonagh, with early career researchers and clinicians to map the state of Pharmacogenomics in 2025. Talks will cover the whole breadth of pharmacogenetic research, from clinical implementation in diverse settings or underrepresented groups to state-of-the-art research on novel application to provide better care for patients.

A provisional programme can be found above with more information to follow

Info: Keynote: ‘Success and challenges of PGx in clinical implementation’

Info: ‘DPYD genetic polymorphisms in patients with severe fluoropyrimidine-related toxicity’

Info: ‘Point of Care Genetics: Pharmacogenetics to Avoid Loss of Hearing UK (PALOH-UK)’

Info: ‘Cancer PGx landscape in the 100k Genomes Project’

Info: Keynote: ‘Pharmacogenomics for drug discovery’

Info: ‘Toward precision care for diabetes in south Asian populations’

Know what’s Happening Next — before everyone else does.

Get App

Host or Publisher Precision Healthcare University Research Institute